Basic Information
Basic information for HCG18-239-39aa-1
Peptide Name HCG18-239-39aa-1
Genome Position chr6:30294225-30294341[-]
Species Human
Peptide Sequence MWTSQQDQDTRKSKCETVNVTSAINRFLNPEILQNFGET
Peptide Length 39
Unique No (HCG18-233-39aa,HCG18-235-39aa-1,HCG18-236-39aa-2,HCG18-237-39aa-1,HCG18-238-39aa-1,HCG18-240-39aa,HCG18-241-39aa-1,HCG18-248-39aa-1,HCG18-249-39aa,HCG18-250-39aa-2,HCG18-251-39aa-2,HCG18-252-39aa-2,HCG18-254-39aa-1,HCG18-255-39aa,HCG18-256-39aa-2,HCG18-257-39aa-2,HCG18-260-39aa-2,HCG18-261-39aa-2,HCG18-263-39aa-2,HCG18-265-39aa-2)
Grand Average of Hydropathicity -0.8795
Relative Molecular Mass 5215.76
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000231074;HCG18
Transcript ID/Name ENST00000454129;HCG18-239
Transcript Length 4433
Coding Ability 0.423
DNA Sequence Corresponding to Peptide ATGTGGACAAGTCAGCAGGATCAGGACACGAGGAAGAGTAAATGTGAGACAGTCAATGTGACTTCTGCGATAAACAGATTTTTAAACCCCGAAATTTTGCAAAATTTTGGTGAAACC
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :